Growth hormone secretagogue combination (GHRH + GHRP)
COP 450.000
A combination of DAC-free CJC-1295 and Ipamorelin, two research peptides being studied for their role in growth hormone secretion. It is being studied in areas such as tissue repair, body composition, and metabolism. Supplied as a lyophilized powder vial (5 mg + 5 mg), intended exclusively for scientific research.
This presentation combines two research peptides that act on complementary pathways of the growth hormone axis:
– CJC-1295 without DAC (also known as modified GRF 1-29): growth hormone-releasing factor (GHRH) analogue.
– Ipamorelin: pentapeptide belonging to the class of secretagogues (GHRP).
Research areas for each component:
– CJC-1295 without DAC: sustained release of growth hormone and regulation of the somatotropic axis.
– Ipamorelin: selective stimulation of growth hormone release with minimal interaction with other hormones.
In research they are studied together because of their complementary action in experimental models.
At KaiLab, peptides are supplied as a freeze-dried powder intended exclusively for scientific research. It is not approved for human or veterinary use.
These recommendations apply to all KaiLab freeze-dried peptides.
Freeze-dried powder (not reconstituted):
– Store at −20 °C for long-term storage.
– Protect from light and keep in a dry environment.
– Under these conditions it maintains its stability for extended periods.
Reconstituted (in solution):
– Reconstitute routinely with bacteriostatic water, under laboratory conditions.
– Store refrigerated (2°C to 8°C).
– Avoid repeated freezing and thawing cycles.
– Handle with aseptic technique and appropriate laboratory equipment.
These instructions pertain solely to the handling of research materials.
This combination is primarily studied in areas related to the growth hormone axis:
– Secretion and release of growth hormone
– Tissue recovery and repair
– Body composition (lean mass and adipose tissue)
– Sleep quality and hormone secretion rhythms
– Metabolism and energy expenditure
The information presented here describes areas of research and does not constitute an indication for use in humans. This product is used solely in controlled research settings.
Product: Combination (two components in one vial)
Component 1: CJC-1295 without DAC (MODIFIED GRF 1-29), CAS 863288-34-0
Component 2: Ipamorelin, CAS 170851-70-4
Molecular class: GHRH analogue (CJC-1295) and GHRP secretagogue (Ipamorelin)
Presentation: Lyophilized powder in vial
Quantity: 5 mg + 5 mg (10 mg total)
Reported purity: ≥99% (HPLC)
Storage: −20 °C, dry environment and protected from light
Reconstitution: Bacteriostatic water (laboratory conditions)
Purity analysis: HPLC by independent laboratory
The compounds are produced under controlled conditions.
Peptides are analyzed using methods such as HPLC.
All orders are shipped in neutral packaging.
KaiLab focuses exclusively on peptides.
Direct answers about what you can expect when buying from KaiLab.
This product is supplied as research material and is not approved for medical or human use.
Documentation may be available for certain lots, upon request.
For greater stability, store the freeze-dried product at −20 °C.
No. This product is intended exclusively for scientific research.
